Smiths Group sells down stake in ICU Medical
announced the sale of 1.2 million shares in ICU Medical on Wednesday, amounting to roughly 4.9% of ICU Medical's issued share capital.
The FTSE 100 company said the transaction was set to generate net proceeds of approximately $152m (£117m) for the group.
It said it planned to use the funds for general corporate purposes.
After the sale, Smiths Group retained a stake in ICU Medical, holding 0.47 million shares, equating to around 1.92% of ICU's issued share capital.
At 0828 BST, shares in Smiths Group were down 0.29% at 1,746p.
Reporting by Josh White for Sharecast.com.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.